2 Weight Loss Drugs Coming Up For Review
The New York Times reports two new approaches to weight loss are coming up for review by federal regulators.
The first is Acomplia, which works by blocking brain receptors resp0onible for the “munchies.”
Second, is Alli, which works by blocking the body’s absorption of fat.
“I think if we could get obesity treatments to a situation like cholesterol where there are several different products, where one or two in combination might be successful, at least that would arm physicians with more than they have now,” said Morgan Downey, executive director of the American Obesity Association, a patients’ advocacy group in Washington.
